Neuroglee

Neuroglee Therapeutics, a startup developing digital therapeutics for people with neurodegenerative diseases, has raised a $10 million Series A led by Openspace Ventures and EDBI. The funding will be used…

Digital therapeutics startup Neuroglee raises $10M to help people with neurodegenerative conditions

There are now about 50 million people with dementia globally, a number the World Health Organization expects to triple by 2050. Alzheimer’s is the leading cause of dementia and caregivers…

Neuroglee gets $2.3 million to develop digital therapeutics for neurodegenerative diseases